manilatimes

AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors

Masivet® is a targeted therapy that inhibits the juxtamembrane mutations of c-kit, which is the main driver of dog mast cell tumors. The MUMS designation is similar to the status of "Orphan Drug” for ...
Yahoo Finance

AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors

AB Science SA (Euronext - FR0010557264 - AB) announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast ...
IEEE

DynPen: Automated Penetration Testing in Dynamic Network Scenarios Using Deep Reinforcement Learning

Abstract: Penetration testing, a crucial industrial practice for securing networked systems and infrastructures, has traditionally depended on the extensive expertise of human professionals.
IEEE

Test Case Selection in Continuous Regression Testing Using Machine Learning: An Industrial Case Study

Abstract: Continuous integration and delivery (CI/CD) have transformed software development by reducing delivery time, improving product quality, and giving enterprises a competitive advantage.